Microbicide Monoclonal Antibody Triple Combination (Polymun)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMicrobicide Monoclonal Antibody Triple Combination (Polymun)
Drug Alias NameC2G12 HIV antibody (Polymun)HIV mAbs (Polymun)C4E10 HIV antibody (Polymun)C2F5 HIV antibody (Polymun)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTransmembrane glycoprotein gp41 inhibitorsHIV envelope protein gp120 inhibitors
TargetsTransmembrane glycoprotein gp41HIV envelope protein gp120
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPolymun Scientific Immunobiologische Forschung GmbH
China Registration ClassN/A

Develop Information

Active CompaniesPolymun Scientific Immunobiologische Forschung GmbH
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A